We find that inhibition of the FEAR pathway in human cancer lines normally resistant to VSVΔM51/VSVM51R infection by hSpt16 RNA interference (RNAi) or curaxin treatment sensitizes these cancer cells to infection with these oncolytic viruses. Here, SUPT16H is linked to infection.